Sven Wehrwein, Director at AtriCure, Inc. (ATRC), sold 15,033 shares at $37.32 ($564K) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Open-market sale of $564k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.32 | 5,033 | $188K | 33.3% |
| 2 | $37.32 | 5,033 | $188K | 33.3% |
| 3 | $38.00 | 4,967 | $189K | 33.4% |
| Total | $37.54 avg | 15,033 | $564K | 100% |
| Filing → |
| ATRC | SELL | 2025-08-26 | $185K | — | Filing → |
| ATRC | SELL | 2025-08-21 | $180K | — | Filing → |
| SPSC | SELL | 2024-08-13 | $725K | — | Filing → |